by Dr. Joe Galati on June 13, 2011
This week, we will be starting therapy using the new FDA approved protease inhibitors, Victrelis (boceprevir) and Incivek (telaprevir) in our patients with chronic hepatitis C.
Below is a brief podcast explaining some of the procedures required prior to initiating therapy with these new agents.
Listen to the podcast here: Hepatitis C Treatment Introduction
Call our office at 713-794-0700 if you have questions.
Liver Specialists of Texas
6624 Fannin, Suite 1990
Houston, TX 77030
____________________
From Mayo
Hepatitis C Treatment
Posted on June 17, 2011 by admin
In this Medical Edge Radio episode, Mayo Clinic Dr. Michael Charlton takes a look at the treatment of Hepatitis C.
To listen, click the link below.
Hepatitis C Treatment
.
No comments:
Post a Comment